A Multicentre, Cohort Study to Assess the Impact on SYMptom Burden and Patient Health-related Quality of Life of Afatinib Treatment in Advanced Non-small Cell Lung Cancer in a Real World Setting in Greece (SYM-Less)

13/04/2016
24/09/2026
EU PAS number:
EUPAS12887
Study
Finalised
Documents
Study protocol
Initial protocol
English (844.54 KB - PDF) View document
Updated protocol
English (844.54 KB - PDF) View document
Study results
Study results
English (234.9 KB - PDF) View document
Study report
No information provided.
ENCePP Seal
No information provided.